Constance Therapeutics, Inc. — Form D
Constance Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-06-26. The offering totals $1.0M, of which $27K was reported sold. Industry: Other.
Offering
- Filed: 2015-06-26
- Form: D
- Accession: 0001646331-15-000001
- Industry: Other
- Exemptions: 04
- Total offering: $1.0M
- Amount sold: $27K
- Remaining: $973K
- Investors: 1
- Date of first sale: 2015-06-10
- Revenue range: Decline to Disclose
- SEC file number: 021-242552
Issuer
- Name: Constance Therapeutics, Inc.
- CIK: 0001646331
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 681 HOWARD STREET, SAN FRANCISCO, CA, 94103
- Phone: 510-455-1473
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Constance Finley | Director | San Francisco, CA |
| Constance Finley | Executive Officer | San Francisco, CA |
| Constance Finley | Promoter | San Francisco, CA |
Other filings by this issuer (2)
More